Theranostic – Money For Lunch

Tag: Theranostic

Clinical stage oncology firm NuView Life Sciences announces a $90 million agreement with international investment group GEM Global Yield for the purpose of developing a promising Theranostic.

Press Releases

Clinical stage oncology firm NuView Life Sciences announces a $90 million agreement with international investment group GEM Global Yield for the purpose of developing a promising Theranostic.

by Community Comments are Disabled

Continue Reading →